North America Medical Aesthetic Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 7.80 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Medical Aesthetic Devices Market Analysis
The North America Medical Aesthetic Devices Market is expected to register a CAGR of 7.8% over the forecast period
COVID-19 pandemic has had a substantial impact on the North America medical aesthetic devices market initially. For instance, an article published in the Journal of Clinics in Dermatology in June 2021 indicated that various procedures, such as deep peeling and laser treatments, were avoided during the COVID-19 pandemic because of the disruptions in the skin barrier. Also, the procedures, such as high-intensity focused ultrasound, fractional radiofrequency, and cryolipolysis equipped with stainless steel, gold, or plastic handpieces and probes, were postponed due to the risk of contamination. However, aesthetic devices that consumers could use in their homes increased after the COVID-19 pandemic. According to an article published in the International Journal of Trichology in February 2022, home-based aesthetic devices have increased in recent years. They became more relevant during the COVID-19 pandemic, as more patients were hesitant to visit clinics for non-emergency reasons. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the market is expected to gain traction due to the significant increase in the use of medical aesthetic devices globally.
Further, the rapidly increasing aging population, increasing obese population and increasing awareness regarding aesthetic procedures and rising adoption of minimally invasive devices are among the major factors driving the growth of the studied market. For instance, in July 2021, Allergan received the US FDA approval of a label expansion of BOTOX to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, pronator teres, and pronator quadratus). Thereby, the approval for minimal invasive procedures is elevating the need for minimally invasive devices, hence this is going to promote the market growth.
Additionally, according to the U.S. Census Bureau, in 2022, it has been stated that more than 56 million adults ages 65 and older live in the United States, accounting for about 16.9% of the nation's population, and by 2030 it is projected that there will be more than 73.1 million older adults. Thereby, such factors are going to elevate the need for cosmetic surgeries and various other procedures which will help a individual look younger, thereby this is going to elevate the growth of the market.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the side effects of the aesthetic devices and poor reimbursement scenario help to restrain the overall market growth.
North America Medical Aesthetic Devices Market Trends
Botulinum Toxin Segment is Expected to Register High Growth During the Forecast Period
Botulinum toxin is a neurotoxic protein produced by the bacterium clostridium botulinum. The botulinum toxin injections tend to block the nerve signals to the muscle in which it is injected. As the muscle cannot contract without a signal, it diminishes or decreases unwanted facial wrinkles or appearance. As a result, highly diluted concentrations of botulinum toxin are used for cosmetic and non-cosmetic purposes, such as for treating frown lines between the eyebrows, dystonia, chronic migraine, and other purposes.
For Instance, according to The American Society of Plastic Surgeons, a survey was released in June 2022 in the United States. It has been mentioned that botulinum toxin Type A is one of the top minimally invasive cosmetic procedures among patients during 2021-2022. It also reported that patients aged 31- 45 years most commonly seek botulinum toxin type A cosmetic procedures. Thereby, such factors are going to elevate the growth of the market.
Additionally, in September 2022, Revance Therapeutics Inc. received approval from USFDA approved DAXXIFY (Daxibotulinumtoxin-A-lanm) for injection for the temporary improvement of moderate to severe frown lines (glabellar lines) in adults. Thereby, such developments are elevating the segment, thereby elevating the market growth.
Therefore, the botulinum toxin segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
United States Holds Significant Share and Expected to do the Same During the Forecast Period
The United States is expected to witness significant growth in the market owing to factors such as the increasing volume of different aesthetic procedures, rising awareness about aesthetic and minimally invasive procedures, and technological advancement in the country are expected to project significant growth.
According to the Aesthetic Society, 2021, it has been stated that the number of dermal filler procedures was around 1,857,339, which is around 32%, within the United States. Thereby, as most people are preferring to undergo such procedures the demand of the market is increasing.
For instance, according to the AAFPRS survey released in March 2022, an estimated 1.4 million surgical and non-surgical procedures were performed in the United States in 2021, an increase of 40% over the procedures performed in 2020. Additionally, according to the ISAPS survey released in December 2021, 860,718 aesthetic procedures were performed in Mexico in 2021, of which 456,489 were aesthetic surgical procedures and 404,229 were non-surgical aesthetic procedures. Thus, the increasing number of cosmetic procedures among the population is anticipated to boost the growth of the market during the forecast period.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the United States.
North America Medical Aesthetic Devices Industry Overview
The North American medical aesthetic devices market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Abbvie Inc. (Allergan PLC), Sisram Medical(Alma Lasers), Cutera Inc., Bausch & Lomb Incorporated, Boston Scientific (Lumenis Inc.), among others.
North America Medical Aesthetic Devices Market Leaders
-
Abbvie Inc. (Allergan PLC)
-
Bausch & Lomb Incorporated
-
Sisram Medical (Alma Lasers)
-
Cutera Inc.
-
Boston Scientific (Lumenis Inc.)
*Disclaimer: Major Players sorted in no particular order
North America Medical Aesthetic Devices Market News
- In June 2022, Cynosure launched the PicoSure Pro device, its latest upgrade to the PicoSure platform. PicoSure Pro is one of the first 755nm picosecond lasers cleared by the US FDA.
- In December 2021, the US Food and Drug Administration (FDA) stated the approval of RHA Redensity.RHA Redensity is a gel implant or dermal filler that is injected in specific areas of facial tissue to reduce the appearance of lines and wrinkles.
North America Medical Aesthetic Devices Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapidly Increasing Aging Population
4.2.2 Increasing Obese Population
4.2.3 Increasing Awareness Regarding Aesthetic Procedures and Rising Adoption of Minimally Invasive Devices
4.3 Market Restraints
4.3.1 Side Effects of the Aesthetic Devices
4.3.2 Poor Reimbursement Scenario
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type of Device
5.1.1 Energy-based Aesthetic Device
5.1.1.1 Laser-based Aesthetic Device
5.1.1.2 Radiofrequency (RF)-based Aesthetic Device
5.1.1.3 Light-based Aesthetic Device
5.1.1.4 Ultrasound Aesthetic Device
5.1.2 Non-energy-based Aesthetic Device
5.1.2.1 Botulinum Toxin
5.1.2.2 Dermal Fillers and Aesthetic Threads
5.1.2.3 Microdermabrasion
5.1.2.4 Implants
5.1.2.5 Other Aesthetic Devices
5.2 By Application
5.2.1 Skin Resurfacing and Tightening
5.2.2 Body Contouring and Cellulite Reduction
5.2.3 Hair Removal
5.2.4 Facial Aesthetic Procedures
5.2.5 Breast Augmentation
5.2.6 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Home Settings
5.4 Geography
5.4.1 United States
5.4.2 Canada
5.4.3 Mexico
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbvie Inc. (Allergan PLC)
6.1.2 Sisram Medical (Alma Lasers)
6.1.3 Cutera Inc.
6.1.4 Bausch & Lomb Incorporated
6.1.5 Galderma SA
6.1.6 Boston Scientific (Lumenis Inc.)
6.1.7 LUTRONIC
6.1.8 Syneron Medical (Candela Corporation)
6.1.9 Venus Concept
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
North America Medical Aesthetic Devices Industry Segmentation
As per the scope of the report, aesthetic devices refer to all medical devices that are used for various cosmetic procedures, which include plastic surgery, unwanted hair removal, excess fat removal, anti-aging, aesthetic implants, skin tightening, and others, that are used for beautification, correction, and improvement of the body. The North America medical aesthetic devices market is segmented by Type of Device (Energy-based Aesthetic Device (Laser-based Aesthetic Device, Radiofrequency (RF) Based Aesthetic Device, Light-based Aesthetic Device, and Ultrasound Aesthetic Device) and Non-energy-based Aesthetic Device (Botulinum Toxin, Dermal Fillers and Aesthetic Threads, Microdermabrasion, Implants, and Other Aesthetic devices)), Application (Skin Resurfacing and Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Facial Aesthetic Procedures, Breast Augmentation, and Other Applications), End-User (Hospitals, Clinics, and Home Settings), and Geography (United States, Canada, and Mexico).
| By Type of Device | |||||||
| |||||||
|
| By Application | |
| Skin Resurfacing and Tightening | |
| Body Contouring and Cellulite Reduction | |
| Hair Removal | |
| Facial Aesthetic Procedures | |
| Breast Augmentation | |
| Other Applications |
| By End User | |
| Hospitals | |
| Clinics | |
| Home Settings |
| Geography | |
| United States | |
| Canada | |
| Mexico |
North America Medical Aesthetic Devices Market Research FAQs
What is the current North America Medical Aesthetic Devices Market size?
The North America Medical Aesthetic Devices Market is projected to register a CAGR of 7.80% during the forecast period (2024-2029)
Who are the key players in North America Medical Aesthetic Devices Market?
Abbvie Inc. (Allergan PLC), Bausch & Lomb Incorporated, Sisram Medical (Alma Lasers), Cutera Inc. and Boston Scientific (Lumenis Inc.) are the major companies operating in the North America Medical Aesthetic Devices Market.
What years does this North America Medical Aesthetic Devices Market cover?
The report covers the North America Medical Aesthetic Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Medical Aesthetic Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
What are the emerging trends in the North American Medical Aesthetics Market?
The emerging trends in the North American Medical Aesthetics Market a) Focus on minimally invasive procedures b) Personalized treatment plans c) Growing adoption of combination therapies
North America Aesthetic Devices Industry Report
The North America Medical Aesthetic Devices industry is on a significant upswing, fueled by a growing demand for aesthetic procedures and technological innovations. With an increase in skin disorders and a higher awareness of beauty devices, the market is expanding rapidly. Innovations in non-surgical and minimally invasive treatments are propelling this growth, alongside investments and collaborations among key players introducing cutting-edge devices. The trend towards procedures that ensure a youthful look without traditional surgery's drawbacks is driving the demand for cosmetic surgeries, especially those that are minimally invasive. The market, segmented by product type and application, sees non-surgical procedures gaining momentum. The emphasis on appearance and advanced devices for skin applications are key trends, supported by diversified services in specialty clinics and hospitals. With statistics and analysis from Mordor Intelligence™ Industry Reports, the North America Aesthetic Devices market's share, size, and revenue growth rate highlight a market poised for continued expansion, driven by innovation, changing beauty standards, and a focus on non-invasive aesthetic enhancements. Get a comprehensive overview and forecast outlook with a free report PDF download from Mordor Intelligence™.
